Is Protalix BioTherapeutics, Inc. (PLX) a Buy, Sell, or Hold?
AMEX : PLX
Protalix BioTherapeutics, Inc. — Insider Trades
$2.5864 USD
$0.16 (6.66%)
- Volume
- 1.76M
- Average Volume
- 697.46K
- Market Capitalization
- $208.39M
- P/E Ratio
- 10.73
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.19
- Year Low
- $1.46
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.94
Insider Activity Summary (Last 12 Months)
Insiders Buying
22
Insiders Selling
1
Amount of Insider Selling
$168
PLX Insider Buying/Selling by Quarter
PLX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Mamlok Gilad | officer: Sr. VP and CFO | 2025-08-24 | 0 | 2026-04-27 | |
| Bashan Dror | director, officer: PRESIDENT AND CEO | 2025-12-19 | P-Purchase | 1.81 | 2025-12-23 |
| Bar-Shalev Amos | director | 2025-11-18 | S-Sale | 1.87 | 2025-11-19 |
| Melincoff Gwen A | director | 2025-09-03 | A-Award | 1.64 | 2025-09-04 |
| Forster Eliot | director | 2025-09-03 | A-Award | 1.64 | 2025-09-04 |
| Forster Eliot | director | 2025-09-03 | A-Award | 0 | 2025-09-04 |
| Melincoff Gwen A | director | 2025-09-03 | A-Award | 0 | 2025-09-04 |
| Boudes Pol F | director | 2025-09-03 | A-Award | 1.64 | 2025-09-04 |
| Boudes Pol F | director | 2025-09-03 | A-Award | 0 | 2025-09-04 |
| Elze Christian | director | 2025-09-03 | A-Award | 1.64 | 2025-09-04 |
| Schwartz Aharon | director | 2025-09-03 | A-Award | 1.64 | 2025-09-04 |
| Elze Christian | director | 2025-09-03 | A-Award | 0 | 2025-09-04 |
| Schwartz Aharon | director | 2025-09-03 | A-Award | 0 | 2025-09-04 |
| Ben Zvi Shmuel | director | 2025-09-03 | A-Award | 1.64 | 2025-09-04 |
| Ben Zvi Shmuel | director | 2025-09-03 | A-Award | 0 | 2025-09-04 |
| Bar-Shalev Amos | director | 2025-09-03 | A-Award | 1.64 | 2025-09-04 |
| Bar-Shalev Amos | director | 2025-09-03 | A-Award | 0 | 2025-09-04 |
| Naos Yaron | officer: Sr. VP, Operations | 2025-09-03 | A-Award | 0 | 2025-09-04 |
| Naos Yaron | officer: Sr. VP, Operations | 2025-09-03 | A-Award | 1.64 | 2025-09-04 |
| Bashan Dror | director, officer: PRESIDENT AND CEO | 2025-09-03 | A-Award | 0 | 2025-09-04 |
| Bashan Dror | director, officer: PRESIDENT AND CEO | 2025-09-03 | A-Award | 1.64 | 2025-09-04 |
| Mamlok Gilad | officer: Sr. VP and CFO | 2025-08-24 | 1.45 | 2025-08-25 | |
| Schwartz Aharon | director | 2025-06-10 | P-Purchase | 1.596 | 2025-08-12 |
| Elze Christian | 2025-06-26 | 0 | 2025-07-03 | ||
| Rubin Eyal | officer: Sr. VP and CFO | 2024-09-23 | A-Award | 0 | 2024-11-05 |
| Rubin Eyal | officer: Sr. VP and CFO | 2024-09-23 | A-Award | 0 | 2024-09-24 |
| Naos Yaron | officer: Sr. VP, Operations | 2024-09-23 | A-Award | 1.1 | 2024-09-24 |
| Bashan Dror | director, officer: PRESIDENT AND CEO | 2024-04-01 | A-Award | 0 | 2024-04-03 |
| Bashan Dror | director, officer: PRESIDENT AND CEO | 2023-10-19 | P-Purchase | 1.41 | 2023-10-20 |
| Bashan Dror | director, officer: PRESIDENT AND CEO | 2023-10-19 | P-Purchase | 1.4 | 2023-10-20 |
| Boudes Pol F | director | 2023-09-29 | A-Award | 1.66 | 2023-10-03 |
| Melincoff Gwen A | director | 2023-09-29 | A-Award | 1.66 | 2023-10-03 |
| Bar-Shalev Amos | director | 2023-09-29 | A-Award | 1.66 | 2023-10-03 |
| Ben Zvi Shmuel | director | 2023-09-29 | A-Award | 1.66 | 2023-10-03 |
| Schwartz Aharon | director | 2023-09-29 | A-Award | 1.66 | 2023-10-03 |
| Forster Eliot | director | 2023-09-14 | A-Award | 1.75 | 2023-09-15 |
| Forster Eliot | director: | 2023-09-14 | 0 | 2023-09-15 | |
| Bashan Dror | director, officer: President and CEO | 2023-08-15 | A-Award | 0 | 2023-08-17 |
| Rubin Eyal | officer: Sr. VP and CFO | 2023-08-15 | A-Award | 0 | 2023-08-17 |
| Hayon Yael | officer: VP, Research & Development | 2023-08-15 | A-Award | 1.99 | 2023-08-17 |
| Hayon Yael | officer: VP, Research & Development | 2023-08-15 | A-Award | 0 | 2023-08-17 |
| Naos Yaron | officer: Sr. VP, Operations | 2023-08-15 | A-Award | 0 | 2023-08-17 |
| Schwartz Aharon | director | 2023-01-03 | P-Purchase | 1.4165 | 2023-01-05 |
| Ben Zvi Shmuel | director: | 2022-09-07 | A-Award | 0 | 2022-09-09 |
| Naos Yaron | officer: Sr. VP, Operations | 2022-09-07 | A-Award | 0 | 2022-09-09 |
| Hayon Yael | officer: VP, Research & Development | 2022-09-07 | A-Award | 0 | 2022-09-09 |
| Rubin Eyal | officer: Sr. VP and CFO | 2022-09-07 | A-Award | 1.03 | 2022-09-09 |
| Rubin Eyal | officer: Sr. VP and CFO | 2022-09-07 | A-Award | 0 | 2022-09-09 |
| Bashan Dror | officer: President and CEO | 2022-09-07 | A-Award | 0 | 2022-09-09 |
| Schwartz Aharon | director: | 2022-09-07 | A-Award | 0 | 2022-09-09 |
| Bronfeld Zeev | director | 2022-09-07 | A-Award | 1.03 | 2022-09-09 |
| Bronfeld Zeev | director: | 2022-09-07 | A-Award | 0 | 2022-09-09 |
| Bar-Shalev Amos | director: | 2022-09-07 | A-Award | 0 | 2022-09-09 |
| Melincoff Gwen A | director | 2022-09-07 | A-Award | 1.03 | 2022-09-09 |
| Melincoff Gwen A | director: | 2022-09-07 | A-Award | 0 | 2022-09-09 |
| Boudes Pol F | director: | 2022-09-07 | A-Award | 0 | 2022-09-09 |
| Ben Zvi Shmuel | director: | 2022-06-30 | A-Award | 0 | 2022-07-05 |
| Ben Zvi Shmuel | director: | 2022-06-30 | 0 | 2022-07-05 | |
| Bashan Dror | officer: President and CEO | 2022-04-11 | P-Purchase | 1.5 | 2022-04-13 |
| Rubin Eyal | officer: Sr. VP and CFO | 2022-02-25 | A-Award | 0 | 2022-02-28 |
| Bashan Dror | director, officer: President and CEO | 2022-02-25 | A-Award | 0 | 2022-02-28 |
| Dexcel Pharma Technologies Ltd. | 10 percent owner | 2021-06-02 | S-Sale | 2.5576 | 2021-06-03 |
| Dexcel Pharma Technologies Ltd. | 10 percent owner | 2021-06-03 | S-Sale | 2.2534 | 2021-06-03 |
| Dexcel Pharma Technologies Ltd. | 10 percent owner | 2021-02-12 | 0 | 2021-02-16 | |
| Dexcel Pharma Technologies Ltd. | 10 percent owner | 2020-03-11 | 2.36 | 2021-02-16 | |
| Rubin Eyal | officer: Sr. VP and CFO | 2020-08-11 | A-Award | 0 | 2020-08-14 |
| Bashan Dror | director, officer: President and CEO | 2020-08-11 | A-Award | 0 | 2020-08-13 |
| Naos Yaron | officer: Sr. VP, Operations | 2020-08-11 | A-Award | 3.59 | 2020-08-13 |
| Hayon Yael | officer: VP, Research & Development | 2020-07-05 | A-Award | 3.73 | 2020-07-08 |
| Hayon Yael | officer | 2020-07-05 | 0 | 2020-07-08 | |
| Almon Einat Brill | officer: SVP, Chief Development Officer | 2020-06-07 | A-Award | 3.59 | 2020-06-08 |
| Schwartz Aharon | director | 2020-04-07 | P-Purchase | 2.426 | 2020-04-13 |
| Bronfeld Zeev | director | 2020-02-03 | A-Award | 3.7 | 2020-02-05 |
| Granot David | director | 2020-01-20 | A-Award | 3.55 | 2020-01-22 |
| Bar-Shalev Amos | director | 2020-01-20 | A-Award | 3.55 | 2020-01-22 |
| Schwartz Aharon | director | 2020-01-20 | A-Award | 3.55 | 2020-01-22 |
| Boudes Pol F | director | 2020-01-20 | A-Award | 3.55 | 2020-01-22 |
| Melincoff Gwen A | director | 2020-01-20 | A-Award | 3.55 | 2020-01-22 |
| Melincoff Gwen A | director: | 2020-01-01 | 0 | 2020-01-03 | |
| Boudes Pol F | director | 2020-01-01 | 0 | 2020-01-03 | |
| Rubin Eyal | officer: Sr. VP & CFO | 2019-09-22 | A-Award | 0.2 | 2019-09-24 |
| Rubin Eyal | officer | 2019-09-22 | 0 | 2019-09-24 | |
| Bashan Dror | director, officer: President & CEO | 2019-06-30 | A-Award | 0.469 | 2019-07-02 |
| Bashan Dror | director, officer: President & CEO | 2019-06-30 | 0 | 2019-07-02 | |
| Maimon Yossi | officer: VP, Chief Financial Officer | 2018-09-13 | A-Award | 0.56 | 2018-09-14 |
| Almon Einat Brill | officer: SVP, Product Development | 2018-09-13 | A-Award | 0.56 | 2018-09-14 |
| Naos Yaron | officer: Sr. VP, Operations | 2018-09-13 | A-Award | 0.56 | 2018-09-14 |
| Manor Moshe | director, officer: President & CEO | 2018-09-13 | A-Award | 0.56 | 2018-09-14 |
| Shaaltiel Yoseph | officer: Executive VP, R&D | 2018-09-13 | A-Award | 0.56 | 2018-09-14 |
| Granot David | director: | 2018-08-09 | 0 | 2018-08-13 | |
| Naos Yaron | officer: Sr. VP, Operations | 2018-05-29 | 0 | 2018-06-08 | |
| Naos Yaron | officer: Sr. VP, Operations | 2018-05-29 | 0 | 2018-06-08 | |
| Naos Yaron | officer: Sr. VP, Operations | 2018-05-29 | 2.65 | 2018-06-08 | |
| Naos Yaron | officer: Sr. VP, Operations | 2018-05-29 | 6.9 | 2018-06-08 | |
| Naos Yaron | officer: Sr. VP, Operations | 2018-05-29 | 1.72 | 2018-06-08 | |
| Manor Moshe | director, officer: President & CEO | 2017-05-16 | P-Purchase | 0.81 | 2017-05-16 |
| Camber Capital Management LLC | 10 percent owner | 2016-12-02 | S-Sale | 0.3168 | 2016-12-06 |
| Shaaltiel Yoseph | officer: Executive VP, R&D | 2016-09-15 | M-Exempt | 0.001 | 2016-09-16 |
| Shaaltiel Yoseph | officer: Executive VP, R&D | 2016-09-15 | M-Exempt | 0.001 | 2016-09-16 |
| Maimon Yossi | officer: Vice President & CFO | 2015-12-14 | P-Purchase | 0.78 | 2015-12-15 |